Fuiano Giorgio, Mancuso Domenico, Cianfrone Paola, Comi Nicola, Mazza Giuseppe, Marino Francesco, Fuiano Laura, Zamboli Pasquale, Caglioti Alfredo, Andreucci Michele
University Magna Graecia, Catanzaro, Italy.
Am J Kidney Dis. 2004 Aug;44(2):257-63. doi: 10.1053/j.ajkd.2004.04.030.
It is not known whether physical exercise increases daily proteinuria in patients with proteinuric nephropathies, thus accelerating progression of the renal lesion. This study evaluates the acute effects of physical exercise on proteinuria in young adults with immunoglobulin A (IgA) nephropathy.
Changes induced by intense physical exercise on quantitative and qualitative proteinuria were evaluated in basal conditions and after 10 days of ramipril therapy in 10 patients with IgA nephropathy, normal glomerular filtration rate (GFR), proteinuria between 0.8 and 1.49 g/24 h, and "glomerular" microhematuria before and after the end of a maximal treadmill Bruce test (B-test). The basal study also was performed in 10 age- and sex-matched healthy volunteers.
At rest, GFR averaged 141 +/- 23 mL/min; it increased by 16.3% +/- 3.3% (P < 0.005) and 7.1% +/- 1.6% at 60 and 120 minutes after the B-test, respectively. At rest, GFR-corrected proteinuria averaged protein of 0.76 +/- 0.21 mg/min/100 mL GFR; it increased to 1.55 +/- 0.28 mg/min/100 mL GFR after 60 minutes (P < 0.001) and declined to 0.60 +/- 0.11 mg/min/100 mL GFR at 120 minutes after the end of the B-test. The pattern of urinary proteins remained unchanged, as did microhematuria. Daily proteinuria was not different from the basal value on the day of the B-test. After ramipril therapy, patients showed a reduction in GFR, but no change in daily GFR-corrected proteinuria, pattern of urinary proteins, or hematuria.
The increase in proteinuria after exercise in our patients is significant and is not prevented by ramipril therapy, but lasts less than 120 minutes. Therefore, it cannot modify daily proteinuria. Thus, these data do not support the need to reduce acute physical activity in patients with nonnephrotic renal diseases.
尚不清楚体育锻炼是否会增加蛋白尿性肾病患者的每日蛋白尿,从而加速肾脏病变的进展。本研究评估了体育锻炼对患有免疫球蛋白A(IgA)肾病的年轻成年人蛋白尿的急性影响。
在10例IgA肾病、肾小球滤过率(GFR)正常、蛋白尿在0.8至1.49 g/24 h之间且有“肾小球性”镜下血尿的患者中,评估了在基础状态下以及雷米普利治疗10天后,剧烈体育锻炼对定量和定性蛋白尿的影响,这些评估在最大运动平板布鲁斯试验(B试验)结束前后进行。还对10名年龄和性别匹配的健康志愿者进行了基础研究。
静息时,GFR平均为141±23 mL/min;在B试验后60分钟和120分钟时分别增加了16.3%±3.3%(P<0.005)和7.1%±1.6%。静息时,经GFR校正的蛋白尿平均为0.76±0.21 mg/min/100 mL GFR;在60分钟后增加至1.55±0.28 mg/min/100 mL GFR(P<0.001),并在B试验结束后120分钟时降至0.60±0.11 mg/min/100 mL GFR。尿蛋白模式和镜下血尿均保持不变。B试验当天的每日蛋白尿与基础值无差异。雷米普利治疗后,患者的GFR降低,但每日经GFR校正的蛋白尿、尿蛋白模式或血尿均无变化。
我们的患者运动后蛋白尿增加显著,且雷米普利治疗无法预防,但持续时间不到120分钟。因此,它不会改变每日蛋白尿。因此,这些数据不支持非肾病性肾脏疾病患者需要减少急性体力活动的观点。